Patent details

Herbas

VPB

Print

EN | LT

LT - USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

EN - USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 16/40
		A61K 39/395
		A61P 3/06

European patent
(11)	Number of the document	3055333
(13)	Kind of document	T
(96)	European patent application number	14802527.3
	Date of filing the European patent application	2014-10-10
(97)	Date of publication of the European application	2016-08-17
(45)	Date of publication and mention of the grant of the patent	2019-12-04
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2014/060109
	Date	2014-10-10

PCT application publication
(87)	Number	WO 2015/054619
	Date	2015-04-16

Priority applications
(30)	Number	Date	Country code
	201361890154 P	2013-10-11	US
	201461923103 P	2014-01-02	US
	201461955514 P	2014-03-19	US
	201462004620 P	2014-05-29	US
	201462025104 P	2014-07-16	US
	14306221	2014-07-31	EP
	201462054571 P	2014-09-24	US
	14306584	2014-10-09	EP

Inventors
(72)	BACCARA-DINET, Marie, FR BESSAC, Laurence, FR CHAUDHARI, Umesh, US HANOTIN, Corinne, FR PORDY, Robert, C., US SASIELA, William, J., US SCHWEMMER GIPE, Daniel A.,, US

Grantee
(73)	Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, US Sanofi Biotechnology, 54 rue La Boétie, 75008 Paris, FR

Title
(54)	USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA
	USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA